IBM’s $10 Billion Quantum Bet and the Software Reality Check

A historic quantum computing milestone has lifted IBM shares, yet the market remains oddly restrained on the broader transformation story. The stock gained 2.5% on Monday to hit €257.70, spurred by a breakthrough at Oak Ridge National Laboratory. But for all the excitement around qubits and fusion materials, the bigger narrative is IBM’s slow-burn pivot from hardware giant to software-and-AI platform — a transition that continues to divide Wall Street.

A Fusion-Fueled Quantum Advance

Working with Oak Ridge, IBM researchers for the first time simulated fusion reactor materials directly on a quantum computer. The team modeled complex molecular structures of FLiBe, a molten salt considered a top candidate for future reactor components. The effort is part of the US Department of Energy’s “Genesis Mission,” aimed at optimizing tritium production for fusion reactors. IBM is marrying classical supercomputers with new quantum resources, targeting a fault-tolerant quantum machine called “Starling” by 2029. Total investment in the strategy exceeds $10 billion.

Software Carries the Weight

Underpinning IBM’s stock story is a quieter shift: software now accounts for 45% of total revenue and roughly two-thirds of operating profit. The hybrid-cloud architecture built on Red Hat OpenShift forms the backbone, while the watsonx platform delivers enterprise-grade AI tools directly into regulated industries. It is a pragmatic, business-first approach that avoids the flashy consumer-AI race. Yet the market still prices IBM’s software growth with caution.

Should investors sell immediately? Or is it worth buying IBM?

Analysts at Bank of America see more torque, reiterating a buy recommendation and raising the price target sharply to $330. The consensus, however, tells a different tale: the median analyst target sits at €256.83, implying just 1.5% upside from Monday’s close. The 14-day RSI at 62.9 sits in neutral territory, and the stock trades 13.45% above its 50-day moving average of €223.02 — a healthy gap, but hardly the stuff of runaway momentum.

A Stock in Two Gears

Since touching a 52-week low of €181.32 in mid-May, IBM shares have surged more than 40%. Yet the current price remains 13.61% below the 52-week high of €292.85 reached on June 1. The stock has clearly broken away from its short-term trend lines, but without the conviction needed to set new records. Institutional capital has flowed toward the margin-rich software business, though the market still appears to discount how quickly that segment can grow.

All eyes now turn to July 22, when IBM reports second-quarter earnings. Bank of America expects a strong print, with the focus on AI demand and software revenue trajectories. A beat could prompt management to raise the full-year free cash flow forecast — the kind of concrete evidence that might finally close the valuation gap between where IBM trades and where its most bullish backers think it should be.